220 likes | 557 Views
Measles resurgence in Africa. Resurgence comes after a period of intensified efforts Since 2000, routine measles vaccination coverage has increased from an estimated 52% to 85% In 2009, 30 African countries experienced measles outbreaks >60,000 reported cases and >1000 reported deaths (WHO)In 20
E N D
1. Challenges in Measles Outbreak ResponsesMSF Perspectives Florence Fermon - Myriam Henkens
10th Annual Measles Initiative Meeting
14/09/2011 Good afternoon
First I would like to thank the meeting organisers to give us the possibility to present some of the challenges we currently meet in the response to the numerous measles outbreak we have to deal with in several countries. Good afternoon
First I would like to thank the meeting organisers to give us the possibility to present some of the challenges we currently meet in the response to the numerous measles outbreak we have to deal with in several countries.
2. Measles resurgence in Africa Resurgence comes after a period of intensified efforts
Since 2000, routine measles vaccination coverage has increased from an estimated 52% to 85%
In 2009, 30 African countries experienced measles outbreaks
>60,000 reported cases and >1000 reported deaths (WHO)
In 2010, 28 countries experienced measles outbreaks
223,000 reported cases and 1200 deaths (WHO)
Real numbers of measles cases and deaths are considerably larger than the numbers reported
WHA resolution (RC61) calls for measles elimination in AFRO by 2020
3. Why the resurgence? Build-up of susceptible children and adolescents
Failure to vaccinate rather than vaccine failure
Programmatic, political and financial challenges
4. 1. Susceptibility build up Two sources of immunity
Natural immunity due to infection
Vaccine derived immunity
As vaccination increases
Less circulating virus
Age distribution of cases changes - a natural consequence of the success of vaccination programs
Children (on average) are older when they become infected
5. Different age distributions These two sources of immunity generate different patterns of susceptibility in the population.
In endemic areas, susceptibility tends to decline sharply with age – the older you are the more likely you are to have already been infected
In areas in transition, we see a slower decline in susceptibility with age because vaccination has reduced but not eliminated the rate of natural infection
And when there is little or no natural infection (as we saw in the Malawi outbreak last year), we see many susceptibles below the age of vaccination, and a very slow decline in susceptibility above the age of vaccination (because being older doesn’t increase your probability of being vaccinated)
These two sources of immunity generate different patterns of susceptibility in the population.
In endemic areas, susceptibility tends to decline sharply with age – the older you are the more likely you are to have already been infected
In areas in transition, we see a slower decline in susceptibility with age because vaccination has reduced but not eliminated the rate of natural infection
And when there is little or no natural infection (as we saw in the Malawi outbreak last year), we see many susceptibles below the age of vaccination, and a very slow decline in susceptibility above the age of vaccination (because being older doesn’t increase your probability of being vaccinated)
6. 2. Failure to vaccinate rather than vaccine failure
7. Programmatic, political and financial challenges Measles victims of MI success and outbreak responses low on politicians and donors agenda
Delays/reluctance in implementing outbreak responses, despite international recommendations
Lack of efficient coordination
Lack of rapid funding
Delays in implementing campaigns - SIAs – despite strong international support (vaccines and operating costs)
DRC 2010 => outbreak 2011
8. MSF & measles outbreak responses Surveillance, treatment, vaccination (when authorized)
2009: Chad, Ethiopia, DRC, Pakistan, Bangladesh, Nigeria, Sudan, Burkina Faso
1.4 million vaccinated, 202 000 treated
2010: Malawi, Chad, DRC, Ethiopia, Yemen, Zimbabwe, Mozambique, Burundi, South Africa, Somalia, Zambia
4.6 million vaccinated 190 000 treated
2011: DRC Bangladesh Burundi, Chad, Ethiopia, Kenya, Niger, Somalia, Zambia
already 3 million vaccinated in DRC only, more than 4 million total in August
More than 50 000 treatments in DRC only
9. Measles outbreak responses in Africa 2004-2011Persons vaccinated – MSF On going 2011 :
Complete package included vaccination : DRC > 17.000 cases, Chad 3 districts, Burundi, Niger
Only surveillance and TTT : Nigeria, Ethiopia
Kenya: Monitoring of the situation at the moment. No access yet
On going 2011 :
Complete package included vaccination : DRC > 17.000 cases, Chad 3 districts, Burundi, Niger
Only surveillance and TTT : Nigeria, Ethiopia
Kenya: Monitoring of the situation at the moment. No access yet
10. Challenges Outbreak detection and recognition
Outbreak response plan
Outbreak response implementation
Outbreak prevention
11. 1. Outbreak detection & recognition Inaccurate (inflated) vaccination coverage data ? biased risk assessment
Weak surveillance system ? late detection of increase in case number
Outbreaks = “failure to vaccinate” ? late official recognition of outbreak (MOH and main actors)
But outbreaks do and will occur in many countries
12. Measles resurgence in Europe/USA So, clear messages should be sent to make sure early official risk assessment and recognition of the problme is facilitate So, clear messages should be sent to make sure early official risk assessment and recognition of the problme is facilitate
13. 2. Outbreak response plan Lack of knowledge of the WHO recommendations
Lack of knowledge of the usefulness of vaccination in outbreak
No standard tools nor technical recommendations for reactive campaigns
Lack of organized technical support (measles >< polio or meningitis)
Confusion with SIAs
Confusion with SIAs
14. 3. Outbreak response implementation Coordination between the different partners
Competition with other priorities (polio campaigns)
Free treatment, increased access to treatment
Timely vaccines availability
Timely funding
15. 4. Outbreak prevention Maintain the number of susceptibles as low as possible
EPI
Flexibility in age range
Immunization included in comprehensive package of care
Special approach to reach children never vaccinated (“reach the un reached”)
Reduce missed opportunities (surveys, health care contacts, etc)
More accurate data in performance, coverage, etc
16. Reaching the unreached
17. Lessons learned, N’djamena, Chad Chronically low vaccine coverage
Failure to reach older children through routine services
Measles-susceptibles built up and to precipitate the 2010 epidemic
18% received their first dose in 2010
previously vaccinated children were easier to reach during the outbreak than unvaccinated children
18. Missed opportunities CAR - Paoua and Congo Brazza - Betou (MSF - 2010)
limited access to care areas
children were not offered vaccination (in or outpatients)
0 to 11 m: 65 to 94% were not immunized according to recommendations
12 to 59 m: 86% to 98% were not immunized and could not be according to the EPI schedules
19. 4. Outbreak prevention (2) SIA / vaccination campaign
Implement TAG recommendations and adjust age group to local epidemiology
Fixed duration of campaigns >< coverage reached
Adapt SIA intervals to needs
Accurate data collection
Independent coverage surveys
Implementation according to plan (DRC 2010)
20. What could be done? Outbreak response included as a component of the Measles Initiative
Outbreak response included into national control programs
Renewed political and financial commitment
Strategies to ensure countries implement SIAs according to plan
Improved coordination in country – Meningitis and Polio could be used as example
Limitations / constraints of implementing recommended strategies should be acknowledged
21. What could be done? (2) Creative strategies
to reduce the missed opportunities,
to reach the unreached
Consider multi Ag campaign (polio, MenA conj, etc)
Develop a risk assessment tool (susceptible population, social determinants, operational strategy)
Develop supporting tools/documents (WHO 2009 recommendations in French, practical accompanying document)
Financial mechanism for rapid response
New vaccines (easy to administer, no cold chain, etc)
22. Acknowledgments MSF teams – field and HQ
Epicentre (Rebecca Grais, Andrea Minetti)
Matthew Ferrari
Thank You For Your Attention